New York And Cambridge
Celtic Therapeutics to Progress RX-10045 for Dry Eye Syndrome Through Phase III Clinical Development
NEW YORK and CAMBRIDGE, Massachusetts, October 26, 2010 - Celtic Therapeutics Holdings L.P.
NEW YORK and CAMBRIDGE, England, May 12, 2010 - Innovation Framework Technologies, the premier supplier of software
solutions dedicated to the innovation and new product development value
chains, today announced its partnership with Cambridge based nu Angle, the
leading technology strategy and roadmapping advisor and implementer.